Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research- Pulawy, Poland

Verified

Basic Information

Site Overview

Source: Human-provided.

Founded as KO-MED more than two decades ago, and acquired by Velocity Clinical Research in 2024, the experienced team at Velocity’s dedicated research site in Puławy conducts clinical trials across a broad variety of indications. By developing strong working relationships with local communities and a robust patient database, Velocity’s Puławy staff provides fast, accurate patient enrollment support, even for diverse populations.Our Puławy team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research. With decades of research experience shared among our investigators in Puławy, Velocity will deliver the right patients, investigators, and research staff for your next research program.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Doctor

Business Subcategory

Source: Human-provided. Doctor
Source: Trial-derived.
6Total Trials
Source: Trial-derived.
0Recruiting Trials
Source: Trial-derived.
1Active Trials
Source: Trial-derived.
4Completed Trials
Source: Trial-derived.
10Unique Conditions
Source: Trial-derived.
3Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Diabetes Mellitus, Type 2 (2)Source: Trial-derived. Atrial Fibrillation (1)Source: Trial-derived. Cardiovascular Risk (1)Source: Trial-derived. Chronic Kidney Disease (1)Source: Trial-derived. Inflammation (1)Source: Trial-derived. Obesity (1)Source: Trial-derived. Overweight (1)Source: Trial-derived. Peripheral Arterial Disease (1)

Sponsors

Source: Trial-derived. Novo Nordisk A/S (4)Source: Trial-derived. Amgen (1)Source: Trial-derived. Bayer (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Echocardiography
Source: AI-inferred. Treadmill / stress testing

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Pharmacokinetic bioanalysis

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom
Source: Google. Wheelchair accessible seating

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Ankle-brachial and toe-brachial index measurement
Source: AI-inferred. App-based insulin dose guidance
Source: AI-inferred. Blood glucose meter monitoring
Source: AI-inferred. Electronic participant diary platform